ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Free Cash Flow Generation Index
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Free Cash Flow Generation Index of 0.02x as of June 2025. Free cash flow of €104.00 Million represents 0% of operating cash flow (€5.16 Billion). Explore LDZU capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ASPEN PHAR.UN.ADR /1 O.N. Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for ASPEN PHAR.UN.ADR /1 O.N. across 4 annual periods. For the full cash flow conversion analysis, see ASPEN PHAR.UN.ADR /1 O.N. operating cash flow efficiency.
Annual Free Cash Flow Generation for ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
Year-by-year Free Cash Flow Generation Index for ASPEN PHAR.UN.ADR /1 O.N.. Check ASPEN PHAR.UN.ADR /1 O.N. (LDZU) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | €104.00 Million | €5.16 Billion | €5.05 Billion | ▼ -81.8% |
| 2024 | 0.11x | €690.00 Million | €6.22 Billion | €5.54 Billion | ▼ -73.8% |
| 2023 | 0.42x | €2.34 Billion | €5.52 Billion | €3.18 Billion | ▼ -14.9% |
| 2022 | 0.50x | €2.68 Billion | €5.37 Billion | €2.70 Billion | — |